Comments on: Monday Biotech Deal Review: January 4, 2010 http://crossborderbiotech.ca/2010/01/04/monday-biotech-deal-review-january-4-2010/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ By: Monday Biotech Deal Review: March 22, 2010 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2010/01/04/monday-biotech-deal-review-january-4-2010/comment-page-1/#comment-1476 Mon, 22 Mar 2010 11:02:54 +0000 http://crossborderbiotech.ca/?p=3856#comment-1476 [...] other news, Prism Medical Ltd. (TSXV: PM), which had struck a special committee to look for shareholder liquidity and value, decided to declare a [...]

]]> By: Monday Biotech Deal Review: February 1, 2010 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2010/01/04/monday-biotech-deal-review-january-4-2010/comment-page-1/#comment-1330 Mon, 01 Feb 2010 12:06:23 +0000 http://crossborderbiotech.ca/?p=3856#comment-1330 [...] Corp. (TSX:RVX) closed a planned second tranche of the PIPE that we covered here, selling $8 million of units, bringing total proceeds to approximately $13 million. The $8 [...]

]]>